This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bcworld Pharm. Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Kwang-Ho Cha: Innovator in Liposome Technology
Introduction
Kwang-Ho Cha is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in the preparation of liposomes. His innovative methods have the potential to enhance drug delivery systems.
Latest Patents
Kwang-Ho Cha holds a patent for a "Method and apparatus for preparing novel liposome." This patent discloses a method for preparing a liposome formulation by dissolving a lipid fraction in an organic solvent. The process involves introducing a supercritical fluid into a reaction vessel containing a solution of a bioactive component and lipid fraction. This method allows for the preparation of proliposome particles, which can be hydrated to form a liposome solution. The formulation can include one or more bioactive components and can be scaled for mass production.
Career Highlights
Kwang-Ho Cha is associated with Bcworld Pharm. Co., Ltd., where he applies his expertise in liposome technology. His work focuses on developing efficient methods for drug formulation that can be utilized in both laboratory and commercial settings.
Collaborations
He has collaborated with notable colleagues such as Sung Joo Hwang and Hee Jun Park, contributing to advancements in pharmaceutical research and development.
Conclusion
Kwang-Ho Cha's innovative approach to liposome preparation represents a significant advancement in pharmaceutical technology. His contributions are poised to impact drug delivery systems positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile